Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort
EP Review Series
Authors: Tarek Bekfani and William T. Abraham
Central sleep apnoea (CSA) occurs in ∼30–50% of patients with heart failure (HF) with reduced left ventricular ejection fraction (LVEF) and in as much as in 18–30% of patients with preserved LVEF. Central sleep apnoea remains often unrecognized due to its chronic and insidious incidences.The development of successful therapies targeting CSA and its harmful downstream effects is therefore important. Large studies to date have been disappointing, but therapeutic options targeting the physiology of the disease may herald a new era in understanding and treating CSA.
Cardio Image Bank
This gallery contains selected images from the European Heart Journal, which have been chosen for their quality and originality. The gallery has been split into subject areas which can be navigated using the links below. Each image entry consists of a thumbnail, title, reference, and legend.
ESC Journal Family Manuscript sharing
Oxford Journals and the European Society of Cardiology (ESC) have introduced a new facility of sharing manuscripts among all ten ESC journals.
Authors submitting to the flagship journal European Heart Journal (EHJ) will, where appropriate, be given the option for their manuscript to be considered by the relevant sub-specialty journal when EHJ is unable to accept their manuscript for publication. EP Europace is included in the sharing system.
Developing Countries Initiative
Early Diagnosis of Acute MI
U. Landmesser and Christian Mueller discuss early diagnosis of acute myocardial infarction at the Cardiology Update 2015, in Davos.